Minerva Neurosciences Statistics Share Statistics Minerva Neurosciences has 6.99M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 6.99M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 25.79% Shares Floating 5.44M Failed to Deliver (FTD) Shares 1,517 FTD / Avg. Volume 11.02%
Short Selling Information The latest short interest is 28.26K, so 0.4% of the outstanding
shares have been sold short.
Short Interest 28.26K Short % of Shares Out 0.4% Short % of Float 0.66% Short Ratio (days to cover) 4.85
Valuation Ratios The PE ratio is 11.68 and the forward
PE ratio is -0.95.
Minerva Neurosciences's PEG ratio is
-0.11.
PE Ratio 11.68 Forward PE -0.95 PS Ratio 0 Forward PS 0.6 PB Ratio 0 P/FCF Ratio -0.86 PEG Ratio -0.11
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Minerva Neurosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.85,
with a Debt / Equity ratio of 0.
Current Ratio 7.85 Quick Ratio 7.85 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -4.79
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $179.88K Employee Count 8 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -38.46% in the
last 52 weeks. The beta is -0.34, so Minerva Neurosciences's
price volatility has been lower than the market average.
Beta -0.34 52-Week Price Change -38.46% 50-Day Moving Average 1.82 200-Day Moving Average 1.93 Relative Strength Index (RSI) 42.29 Average Volume (20 Days) 13,762
Income Statement
Revenue n/a Gross Profit n/a Operating Income -21.85M Net Income 1.44M EBITDA 6.02M EBIT 6M Earnings Per Share (EPS) 0.19
Full Income Statement Balance Sheet The company has 21.36M in cash and 0 in
debt, giving a net cash position of 21.36M.
Cash & Cash Equivalents 21.36M Total Debt n/a Net Cash n/a Retained Earnings -395.38B Total Assets 37.14M Working Capital 19.43M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -19.55M
and capital expenditures 0, giving a free cash flow of -19.55M.
Operating Cash Flow -19.55M Capital Expenditures n/a Free Cash Flow -19.55M FCF Per Share -2.58
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields NERV does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for NERV is $5,
which is 184.1% higher than the current price. The consensus rating is "Hold".
Price Target $5 Price Target Difference 184.1% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $0.95 Lynch Upside -46.02% Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 21, 2022. It was a
backward
split with a ratio of 1:8.
Last Split Date Jun 21, 2022 Split Type backward Split Ratio 1:8
Scores Altman Z-Score -13.39 Piotroski F-Score 4
